Controlled-release hydromorphone and risk of infection in adults: a systematic review

BACKGROUND: Preliminary evidence suggests that people who inject drugs (PWID) may be at an increased risk of developing infective endocarditis (IE), hepatitis C virus (HCV) infection, and/or human immunodeficiency virus (HIV) infection from hydromorphone controlled-release formulation. The hypothesi...

Descripción completa

Detalles Bibliográficos
Autores principales: Tricco, Andrea C., Parker, Amanda, Hezam, Areej, Nincic, Vera, Yazdi, Fatemeh, Lai, Yonda, Harris, Charmalee, Bouck, Zachary, Bayoumi, Ahmed M., Straus, Sharon E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142404/
https://www.ncbi.nlm.nih.gov/pubmed/37118805
http://dx.doi.org/10.1186/s12954-023-00788-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142404/
https://www.ncbi.nlm.nih.gov/pubmed/37118805
http://dx.doi.org/10.1186/s12954-023-00788-9

Ejemplares similares